West Point
-
West Point’s Merck Discontinues Development of Experimental COVID-19 Drug
Merck, the pharmaceutical giant with sizable operations in West Point, has decided to discontinue the development of the experimental COVID-19 drug it acquired from a $425 million acquisition of OncoImmune late last year, writes Berkeley Lovelace Jr. for CNBC. The company decided to end the development of MK-7110 after the Food and Drug Administration asked…
-
Merck’s West Point Factory Will Help Produce Johnson & Johnson’s COVID-19 Vaccine
Merck’s factory in West Point will help produce Johnson & Johnson’s COVID-19 vaccine, writes Harold Brubaker for The Philadelphia Inquirer. The Montgomery County plant, which is also Merck’s largest pharmaceutical plant, will mix the key drug component of the vaccine with other ingredients and fill vials with the finished product. At the earliest, the work…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
